US 7459426
Methods of using IL-1 antagonists to treat autoinflammatory disease
granted A61KA61K38/00A61K38/177
Quick answer
US patent 7459426 (Methods of using IL-1 antagonists to treat autoinflammatory disease) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00, A61K38/177, A61K45/06, A61P